The Pharmacological Sciences Training Program is designed to provide predoctoral students with a strong foundation in basic pharmacological principles and a broad knowledge of other related basic science disciplines, including biochemistry and medicinal chemistry. All students will complete a core pharmacological sciences curriculum consisting of courses in pharmacology and biological chemistry, with other courses designed to fit the programmatic needs of individual students. Students may follow one of two general tracks with emphasis on biological or chemical research. In the Biology Track, a degree may be obtained in pharmacology, biological chemistry, pharmaceutical sciences, molecular and integrative physiology, or toxicology. In the Chemistry Track, a degree may be obtained in medicinal chemistry, chemistry, biological chemistry, or pharmaceutical sciences. Areas of research concentration within the program include cardiovascular/renal pharmacology, neuropharmacology, xenobiotic metabolism, growth and metabolic regulation, receptor structure and function, synthesis and pharmacology of therapeutic and diagnostic agents, transport mechanisms, drug absorption, drug delivery, and pharmacokinetics. Students obtain laboratory experience in several types of pharmacological research and learn how to design experiments, evaluate experimental data, and use appropriate statistical methods. The training program includes graduate-level courses with lectures, discussions, and examinations; seminar programs; supervised laboratory investigation leading to an independent study that forms the basis for the student's doctoral dissertation; a preliminary examination, and a final oral examination, during which the trainee defends the dissertation before a doctoral committee. Support is requested for 16 trainees per year. Highly qualified students with an interest in pharmacological sciences are selected from among the students enrolled in the participating departments. Selection of students is based on undergraduate and graduate GPA, GRE scores, research experience, letters of recommendation, performance in course work and research rotations in graduate school, and personal interviews. Students enter the PSTP at the beginning of their second year of graduate school and are generally supported by the training grant for two years. Rigorous policies of admissions, course grades, qualifying exams, laboratory experiences, and thesis work are enforced to maintain a high level of quality. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007767-31
Application #
7458922
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
1978-07-01
Project End
2011-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
31
Fiscal Year
2008
Total Cost
$599,947
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Masureel, Matthieu; Zou, Yaozhong; Picard, Louis-Philippe et al. (2018) Structural insights into binding specificity, efficacy and bias of a ?2AR partial agonist. Nat Chem Biol 14:1059-1066
Sanchez, Jaquelyn N; Wang, Ton; Cohen, Mark S (2018) BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers. Drugs 78:549-566
Epling, Daniel; Hu, Yongjun; Smith, David E (2018) Evaluating the intestinal and oral absorption of the prodrug valacyclovir in wildtype and huPepT1 transgenic mice. Biochem Pharmacol 155:1-7
Drake, Lindsey R; Scott, Peter J H (2018) DARK Classics in Chemical Neuroscience: Cocaine. ACS Chem Neurosci 9:2358-2372
Lamberts, Jennifer T; Rosenthal, Lisa D; Jutkiewicz, Emily M et al. (2018) Role of the guanine nucleotide binding protein, G?o, in the development of morphine tolerance and dependence. Psychopharmacology (Berl) 235:71-82
Beyett, Tyler S; Gan, Xinmin; Reilly, Shannon M et al. (2018) Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKK? for the treatment of obesity. Bioorg Med Chem 26:5443-5461
Senese, Nicolas B; Oginsky, Max; Neubig, Richard R et al. (2018) Role of hippocampal 5-HT1A receptors in the antidepressant-like phenotype of mice expressing RGS-insensitive G?i2 protein. Neuropharmacology 141:296-304
Zwicker, Jeffery D; Diaz, Nicolas A; Guerra, Alfredo J et al. (2018) Optimization of dipeptidic inhibitors of cathepsin L for improved Toxoplasma gondii selectivity and CNS permeability. Bioorg Med Chem Lett 28:1972-1980
Stanczyk, M Alexander; Kandasamy, Ram (2018) Biased agonism: the quest for the analgesic holy grail. Pain Rep 3:e650
Maust, Joel D; Frankowski-McGregor, Christy L; Bankhead 3rd, Armand et al. (2018) Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers. Mol Cancer Ther 17:2495-2506

Showing the most recent 10 out of 325 publications